Results 201 to 210 of about 30,220 (240)

Emergence of OXA-48-producing Klebsiella pneumoniae in Lithuania, 2023: a multi-cluster, multi-hospital outbreak. [PDF]

Euro Surveill
Greičius P, Linkevicius M, Razmuk J, Sinotova J, Alm E, Svartström O, Bortolaia V, Kudirkienė E, Roer L, Hendriksen RS, Tamoliūnaitė G, Palm D, Monnet DL, Kohlenberg A, Griškevičius A.   +14 more
europepmc   +1 more source

Evaluation of the KPC/IMP/NDM/VIM/OXA-48 Combo Test Kit and Carbapenem-Resistant K.N.I.V.O. Detection K-Set in detecting KPC variants. [PDF]

J Clin Microbiol
Valério de Lima A, Lima KdO, Cappellano P, Cifuentes S, Lincopan N, Sampaio SCF, Sampaio JLM.   +6 more
europepmc   +1 more source

Ceftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region. [PDF]

Antibiotics (Basel)
Dumlu R, Şahin M, Derin O, Gül Ö, Başgönül S, Zengin R, Arabacı Ç, Şimşek F, Gençer S, Kocagöz AS, Mert A.   +10 more
europepmc   +1 more source

Electrostatic interactions define nacubactam potency against OXA-48-like β-lactamases

Hoff JF, Goudar KE, Beer M, Hinchliffe P, Shaw JM, Tooke CL, Takebayashi Y, Mulholland AJ, Schofield CJ, Spencer J.   +9 more
europepmc   +1 more source

Role of amino acid 159 in carbapenem and temocillin hydrolysis of OXA-933, a novel OXA-48 variant. [PDF]

Antimicrob Agents Chemother
Rima M, Oueslati S, Cotelon G, Creton E, Bonnin RA, Dortet L, Iorga BI, Naas T.   +7 more
europepmc   +1 more source